This is a StreetInsider.com Premium Only Page

Kitov Pharma (KTOV) –

Jan 18, 2021 07:41 AM Purple Biotech to Present at the B. Riley Oncology Investor Conference

Jan 4, 2021 09:40 AM Purple Biotech to Ring the Nasdaq Stock Market Opening Bell

Dec 10, 2020 08:19 AM Form 6-K Kitov Pharma Ltd. For: Dec 10

Dec 10, 2020 08:18 AM Kitov Announces Name Change to Purple Biotech Ltd.

Dec 3, 2020 04:03 PM Form 6-K Kitov Pharma Ltd. For: Dec 03

Nov 23, 2020 04:16 PM Form 25-NSE Kitov Pharma Ltd. Filed by: The Nasdaq Stock Market LLC

Nov 12, 2020 08:37 AM Form 6-K Kitov Pharma Ltd. For: Nov 12

Nov 11, 2020 07:25 AM Kitov Pharma to Participate in November Investor Conferences

Nov 9, 2020 07:32 AM Form 6-K Kitov Pharma Ltd. For: Nov 09

Nov 9, 2020 07:30 AM Kitov Expands Planned Phase 1/2 Clinical Trial of CM24 in Non-Small Cell Lung Cancer with New Cohort to Evaluate CM24 in Patients with Pancreatic Cancer Conducted with Bristol Myers Squibb

Oct 27, 2020 10:28 AM Form 6-K Kitov Pharma Ltd. For: Oct 27

Oct 27, 2020 08:03 AM Kitov Pharma (KTOV) Receives Notice of Allowance for a U.S. Patent Covering its Anti-Cancer Drug Candidate, NT219

Oct 27, 2020 08:03 AM Kitov Pharma Receives Notice of Allowance for a U.S. Patent Covering its Anti-Cancer Drug Candidate, NT219

Oct 22, 2020 04:11 PM Form 6-K Kitov Pharma Ltd. For: Oct 22

Oct 16, 2020 03:02 PM Form 6-K Kitov Pharma Ltd. For: Oct 16

Oct 16, 2020 07:33 AM Kitov Pharma (KTOV) Highlights Results Supporting New Mechanism of Action Data for NT219

Oct 16, 2020 07:21 AM New Mechanism of Action Data for NT219 Presented at Epigenetics and Metabolism AACR Special Virtual Conference

Sep 8, 2020 07:45 AM Form 6-K Kitov Pharma Ltd. For: Sep 08

Sep 8, 2020 07:14 AM Kitov Pharma (KTOV) Reports First Patient Dosing in Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients

Sep 8, 2020 07:10 AM Kitov Announces Dosing of First Patient in Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients

Sep 8, 2020 06:36 AM Form 6-K Kitov Pharma Ltd. For: Sep 08

Sep 4, 2020 08:01 AM Kitov Pharma (KTOV) Receives Notice of Intention to Grant Two Patents in China Covering Company’s Lead Oncology Assets, CM24 and NT219

Sep 4, 2020 08:00 AM Kitov Pharma Receives Notice of Intention to Grant Two Patents in China Covering Company’s Lead Oncology Assets, CM24 and NT219

Aug 17, 2020 06:26 AM Form 6-K Kitov Pharma Ltd. For: Aug 16

Aug 12, 2020 04:55 PM Kitov Pharma Announces ADS Ratio Change

Aug 12, 2020 04:52 PM Form 6-K Kitov Pharma Ltd. For: Aug 12

Aug 11, 2020 08:22 AM Form 6-K Kitov Pharma Ltd. For: Aug 11

Aug 11, 2020 07:15 AM Kitov Pharma Provides Corporate Update and Reports First Half 2020 Financial Results

Aug 7, 2020 06:10 AM Form 6-K Kitov Pharma Ltd. For: Aug 06

Jul 20, 2020 06:03 AM Form EFFECT Kitov Pharma Ltd.

Jul 20, 2020 06:03 AM Form EFFECT Kitov Pharma Ltd.

Jul 14, 2020 04:04 PM Form D Kitov Pharma Ltd.

Jul 10, 2020 04:36 PM Form POS AM Kitov Pharma Ltd.

Jul 10, 2020 04:32 PM Form F-3 Kitov Pharma Ltd.

Jul 9, 2020 07:33 AM Kitov Pharma (KTOV) Begins Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients

Jul 9, 2020 07:32 AM Form 6-K Kitov Pharma Ltd. For: Jul 09

Jul 9, 2020 07:30 AM Kitov Announces Initiation of Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients

Jul 8, 2020 07:31 AM Form 6-K Kitov Pharma Ltd. For: Jul 08

Jul 8, 2020 07:30 AM Kitov Pharma (KTOV) Receives Notice of Intention to Grant European Patent Covering CM24, its anti-CEACAM1 Antibody

Jul 8, 2020 07:30 AM Kitov Pharma Receives Notice of Intention to Grant a European Patent Covering CM24, its anti-CEACAM1 Antibody

Jul 6, 2020 05:00 PM Form SC 13G Kitov Pharma Ltd. Filed by: ARMISTICE CAPITAL, LLC

Jul 2, 2020 04:19 PM Form 6-K Kitov Pharma Ltd. For: Jul 02

Jul 2, 2020 08:47 AM Kitov Pharma (KTOV) Issues CEO Shareholder Letter Providing Business Update

Jul 2, 2020 08:36 AM Form 6-K Kitov Pharma Ltd. For: Jul 02

Jul 2, 2020 08:34 AM Kitov Pharma Issues CEO Shareholder Letter Providing Business Update

Jul 1, 2020 04:50 PM Form 6-K Kitov Pharma Ltd. For: Jul 01

Jun 30, 2020 06:25 AM Form 6-K/A Kitov Pharma Ltd. For: Jun 29

Jun 25, 2020 04:31 PM Form 6-K Kitov Pharma Ltd. For: Jun 25

Jun 25, 2020 04:30 PM Kitov Closes $35.0 Million Registered Direct Offering

Jun 25, 2020 11:17 AM Form 6-K Kitov Pharma Ltd. For: Jun 25